|
Volumn 20, Issue 2, 1987, Pages 137-144
|
Phase I clinical trial of recombinant human tumor necrosis factor
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
TUMOR NECROSIS FACTOR;
CARDIOVASCULAR SYSTEM;
CLINICAL ARTICLE;
DRUG CLEARANCE;
DRUG HALF LIFE;
HUMAN;
HYPOTENSION;
INTOXICATION;
INTRAVENOUS DRUG ADMINISTRATION;
PHARMACOKINETICS;
PHASE 1 CLINICAL TRIAL;
THERAPY;
ADULT;
AGED;
DRUG EVALUATION;
FEMALE;
HUMAN;
HYPOTENSION;
LIVER;
MALE;
MIDDLE AGE;
NEOPLASMS;
RECOMBINANT PROTEINS;
TUMOR NECROSIS FACTOR;
|
EID: 0023629556
PISSN: 03445704
EISSN: 14320843
Source Type: Journal
DOI: 10.1007/BF00253968 Document Type: Article |
Times cited : (128)
|
References (12)
|